145 related articles for article (PubMed ID: 8968072)
1. Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats.
Cha RS; Guerra L; Thilly WG; Zarbl H
Carcinogenesis; 1996 Nov; 17(11):2519-24. PubMed ID: 8968072
[TBL] [Abstract][Full Text] [Related]
2. Dietary N-3 fatty acids do not affect induction of Ha-ras mutations in mammary glands of NMU-treated rats.
Ronai Z; Lau YY; Cohen LA
Mol Carcinog; 1991; 4(2):120-8. PubMed ID: 2043252
[TBL] [Abstract][Full Text] [Related]
3. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations.
Cha RS; Thilly WG; Zarbl H
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3749-53. PubMed ID: 8170982
[TBL] [Abstract][Full Text] [Related]
4. The role of Ha-ras oncogenes in growth factor independence in rat mammary carcinoma cells.
Chiodino C; Jones RF; Ethier SP
Mol Carcinog; 1991; 4(4):286-96. PubMed ID: 1908245
[TBL] [Abstract][Full Text] [Related]
5. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
[TBL] [Abstract][Full Text] [Related]
6. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
[TBL] [Abstract][Full Text] [Related]
7. Ha-ras oncogene activation in mammary glands of N-methyl-N-nitrosourea-treated rats genetically resistant to mammary adenocarcinogenesis.
Lu SJ; Archer MC
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):1001-5. PubMed ID: 1736280
[TBL] [Abstract][Full Text] [Related]
8. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
[TBL] [Abstract][Full Text] [Related]
9. Mutational activation of c-Ha-ras genes in intraductal proliferation induced by N-nitroso-N-methylurea in rat mammary glands.
Sakai H; Ogawa K
Int J Cancer; 1991 Aug; 49(1):140-4. PubMed ID: 1874567
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors.
McKenzie KE; Armstrong BA; Chen Y; Nagarajan M; Aldaz CM; Sukumar S
Mol Carcinog; 1997 Oct; 20(2):194-203. PubMed ID: 9364209
[TBL] [Abstract][Full Text] [Related]
11. The stroma as a crucial target in rat mammary gland carcinogenesis.
Maffini MV; Soto AM; Calabro JM; Ucci AA; Sonnenschein C
J Cell Sci; 2004 Mar; 117(Pt 8):1495-502. PubMed ID: 14996910
[TBL] [Abstract][Full Text] [Related]
12. Absence of Ras mutations in rat DMBA-induced mammary tumors.
Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
[TBL] [Abstract][Full Text] [Related]
13. Role of DNA repair in carcinogen-induced ras mutation.
Engelbergs J; Thomale J; Rajewsky MF
Mutat Res; 2000 May; 450(1-2):139-53. PubMed ID: 10838139
[TBL] [Abstract][Full Text] [Related]
14. ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.
Thompson TA; Haag JD; Gould MN
Carcinogenesis; 2000 Oct; 21(10):1917-22. PubMed ID: 11023551
[TBL] [Abstract][Full Text] [Related]
15. Effect of dietary fat or tamoxifen on the expansion of cells harboring Ha-ras oncogenes in mammary glands from methylnitrosourea-treated rats.
Hu Z; Chaulk JE; Lu SJ; Xu Z; Archer MC
Carcinogenesis; 1995 Sep; 16(9):2281-4. PubMed ID: 7554092
[TBL] [Abstract][Full Text] [Related]
16. Comparison of O6-methylguanine-DNA methyltransferase mRNA levels in Ha-ras mutated and non-mutated rat mammary tumors induced by N-methyl-N-nitrosourea.
Inui H; Watatani M; Yasutomi M; Nishisho I
Carcinogenesis; 1994 Mar; 15(3):459-63. PubMed ID: 8118929
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: role of Ha-ras mutations and use of microarray analysis in identifying potential targets.
Yao R; Wang Y; Lu Y; Lemon WJ; End DW; Grubbs CJ; Lubet RA; You M
Carcinogenesis; 2006 Jul; 27(7):1420-31. PubMed ID: 16403772
[TBL] [Abstract][Full Text] [Related]
18. Absence of p53 mutations in methylnitrosourea-induced mammary tumors in rats.
Ogawa K; Tokusashi Y; Fukuda I
Cancer Detect Prev; 1996; 20(3):214-7. PubMed ID: 8769715
[TBL] [Abstract][Full Text] [Related]
19. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
